-transparent.png){kind=logo}
In mice, long-term reductions in striatal DA produced by the neurotoxin MPTP were completely prevented by its combined administration with amphetamine. Depletion of DA from DA terminals by cotreatment with reserpine did not suppress but rather enhanced MPTP-induced DA decrements in striatum. Amphetamine protection against DA neurotoxicity of MPTP in mice is probably not due to increases in DA release and may be related to inhibition of MPTP transport into nigrostriatal terminals via the DA reuptake system.
Related Publications
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
February 2001,
Brain research,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
October 2007,
Brain research,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
December 2004,
Brain research,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
July 1999,
Movement disorders : official journal of the Movement Disorder Society,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
January 1994,
European journal of pharmacology,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
June 2010,
Brain research,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
December 2005,
The Journal of biological chemistry,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
September 2007,
The European journal of neuroscience,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
May 2006,
Brain research,
E Melamed, and
J Rosenthal, and
O Cohen, and
A Uzzan, and
M Globus
January 2022,
Evidence-based complementary and alternative medicine : eCAM,
